Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Increased incidence of thyroid cancer

Firas Baidoun • 5 Jun 2022
ASCO 2022
Thyroid Cancer

Firas Baidoun, MD, Cleveland Clinic, Cleveland, OH, reflects on challenges associated with the treatment and management of thyroid cancer, including increased incidence due to new diagnostic modalities. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Firas Baidoun

3:28
Impact of intensive multimodal treatment on outcomes in anaplastic thyroid cancer
Firas Baidoun • 5 Jun 2022
2:35
Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastases
Firas Baidoun • 7 Jul 2021
1:37
Impact of gender and HPV status on anal squamous cell carcinoma survival
Firas Baidoun • 7 Jul 2021

Related Videos

3:19
Future directions of targeted agents in the treatment of thyroid and neuroendocrine tumors
Enrique Grande • 22 Oct 2023
3:42
AI analysis of TILs in H&E slides to explore immune phenotypes in papillary thyroid cancer
Young Kwang Chae • 4 Jun 2023
2:10
Exploring the new frontier: radionuclide therapy in metastatic prostate cancer
Jeremie Calais • 3 Jun 2023
1:17
Evaluating the genomic landscape of thyroid cancer
Blessie Elizabeth Nelson • 17 Apr 2023
The content of VJOncology is intended for healthcare professionals